Charles Matine - 09 Jun 2023 Form 4 Insider Report for Bionik Laboratories Corp. (BNKL)

Role
Director
Signature
/s/ Charles Matine
Issuer symbol
BNKL
Transactions as of
09 Jun 2023
Transactions value $
$108,333
Form type
4
Filing time
21 Jun 2023, 10:57:58 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNKL Common Stock, par value $0.001 per share Purchase $108,333 +180,555 +683% $0.6 206,985 09 Jun 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person acquired the shares of common stock in lieu of cash payment for $108,333 in accrued and unpaid fees relating to reporting person's services as a director of the Issuer.